Combihale (0.5mg+2.5mg/2.5mL) nebulizer solution

Introduction

Expert Advice

Indications:

This medicine is used for the prevention and treatment of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and mild to moderate asthma.

Administration:

This medicine is used with a nebulizer, a machine which changes the solution form into a gaseous form. This gas/mist is then inhaled. The solution must be colorless. Each treatment session usually takes 5-15 minutes.

Make sure to clean the nebulizer to prevent infections. The dosage of this medicine is dependent on the patient’s age, condition and its severity. Please consult your health care provider before use of this medicine.

Storage:

Please store this medicine at room temperature (20-30 Celsius). Keep medicine away from excessive light, moisture, and children.

Side Effects:

Patients administered with this medication may experience headache, dizziness, throat irritation, cough, dry mouth, and nausea. Patients may also experience constipation, urinary retention (inability to urinate completely), occasional paradoxical bronchospasm (narrowing or spasm of airway), tachycardia (increased heart rate), and arrhythmias (disorder of heart rhythm)

Precautions:

This medicine's use should be closely monitored in conditons like glaucoma (Increased intraoccular eye pressure), prostatic hypertrophy (increased number of prostate gland cells) and bladder outlet obstruction (bladder outflow blockage). Protect eyes from this medicine as it may cause irriation. 

Effects on pregnancy and lactation:

The effects are undetermined; therefore, caution is advised. Please consult your health care provider before use.

Contraindications:

This medication is contraindicated in case of hypersensitivity to the active substance i.e. ipratropium bromide or to atropine. 

Primary Uses

Indications

This medicine is used for the prevention and treatment of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis and mild to moderate asthma.

Side Effects

Patients administered with this medication may experience headache, dizziness, throat irritation, cough, dry mouth, and nausea. Patients may also experience constipation, urinary retention (inability to urinate completely), occasional paradoxical bronchospasm (narrowing or spasm of airway), tachycardia (increased heart rate), and arrhythmias (disorder of heart rhythm)